Dr Lal PathLabs eyes 18% top-line growth in FY17

27 Jun 2016 Evaluate

Dr Lal PathLabs is eyeing to attain around 18% growth in its top-line in FY17 as it undertakes initiatives to expand number of tests offered and its network across India. The company would be adding 15 labs and around 200 collection centres, which are mainly franchise outlets during the fiscal year. Moreover, the company is likely to invest around Rs 40 crore for the same.

The company is also planning to expand in to South and West India. In south and west it has selected two cities Bengaluru and Pune. In these cities, it will develop critical mass and then expand.

Dr LalPath Labs has 172 clinical labs and one central laboratory, over 1,500 collection centres and 4,967 pick-up points. It currently conducts nearly 2,000 tests. The company had posted a revenue of Rs 791.3 crore for the fiscal year 2015-16.

Dr. Lal Pathlabs Share Price

2953.35 -67.15 (-2.22%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7248.75
Max Healthcare Inst 1166.60
Narayana Hrudayalay 1286.30
Aster DM Healthcare 486.85
Global Health 1098.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.